Stephen Taylor

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

Leo Swadling, Mariana O. Diniz, Nathalie Schmidt et al. · Nature · 2021 · 426 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

Jianmin Zuo, Alexander C. Dowell, Hayden Pearce et al. · Nature Immunology · 2021 · 422 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose

Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons et al. · Science · 2021 · 385 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immune boosting by B.1.1.529 <b>(</b> Omicron) depends on previous SARS-CoV-2 exposure

Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons et al. · Science · 2022 · 359 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold et al. · Nature Medicine · 2020 · 340 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12